Skip to contentL
Lifecore Biomedical, Inc.
L
LFCRLifecore Biomedical, Inc. Q1 2018 · 10-Q
Revenue$115.78M$115.78M+6.2% vs Q1 2017 Net Income$2.15M$2.15M−35.2% vs Q1 2017 EPS Diluted$0.08$0.08−33.3% vs Q1 2017 Gross Profit$18,802,000−6.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lifecore Biomedical, Inc. · CIK 1005286 · Engraved from SEC EDGAR
Operating Cash Flow$3,450,000−65.4% Free Cash Flowderived-$2,277,000N/M Margins · derivedGross margin16.2%−2.2 pt vs Q1 2017
Operating margin2.4%−2.7 pt vs Q1 2017
Net margin1.9%−1.2 pt vs Q1 2017
ended Aug 27, 2017 · filed Sep 28, 2017 · 32 d after period end